
Peptide appearance
Lyophilized form helps protect peptide quality. Peptides are supplied as a dry powder, which may look like a compact "puck" or a lighter powder inside the vial.
Because the peptide is dry, it does not require refrigerated shipping during normal transit, including warm seasonal conditions. For longer storage, follow the storage guidance in the product description.
Appearance can vary. The stated peptide content is checked through third-party analysis.
Read more in the product description.
Solution not bundled
Peptides are delivered as lyophilized powder. This dry form helps preserve peptide quality during storage and transport and does not require refrigerated shipping during normal transit.
To prepare a solution, use a solvent such as Bacteriostatic water. It is sold separately, so add it only when you need it for peptide preparation.
Read more in the product description.
Melanocortin research peptide
Melanotan-1
In stock
A linear alpha-MSH analogue used in melanocortin receptor studies.
Order within — · ships today Cutoff 10:00 · local time
Arrives Sep 21 - Sep 23 to Europe
Melanotan-1
39,90 €
Linear alpha-MSH analogue for MC1R and melanocortin pathway comparison.
Scroll horizontally to reach every product-information tab.
Research overview
Melanotan-1
Melanotan-1 is a catalogue name associated with the synthetic peptide afamelanotide, a linear alpha-MSH analogue.
Research examines its peptide structure, stability, and melanocortin receptor pharmacology. The listed sources are a research starting point rather than a substitute for product evidence: the supplied material's exact form, lot, and measured characteristics must be established through its signed analytical record.
Compound information
Specifications
Molecular profile
- Sequence
- Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2
- Molecular mass
- 1646.8 g/mol
- CAS number
- 75921-69-6
- Molecular formula
- C78H111N21O19
Material record
- Physical appearance
- White to off-white lyophilized powder
- Solubility
- Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
- Product note
- Synthetic alpha-MSH / melanocortin analogue; studied for MC1R and melanocortin receptor pathway research; supplied strictly for research use only.
Laboratory care
Handling
Peptides in transport
Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.
Storage of lyophilized peptides
Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Up to 3 months
- Refrigerated (2–8 °C): Up to 6 months
- Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)
Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.
Storage of reconstituted peptides
Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.
The following storage conditions are generally recommended:
- Room temperature (15–25 °C): Avoid prolonged storage
- Refrigerated (2–8 °C): Typically 4–8 weeks
- Frozen (-20 °C or below): Up to 3–4 months
To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.
Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.
Analytical documentation
Latest test results
Latest published result
Liquilabs s.r.o.Signed Certificate of Analysis · 10mg
99.8%Purity by HPLC
Recorded QC panel
- AssayPeptide screening
- 10.00 mg
- PurityPeptide screening
- 99.8%
- Identity (FTIR)FTIR spectrum
- 994
- Identity (RT)Retention time
- 0.992
- Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
- 0.017 EU/mg
- Molecular Ion MassMS deconvolution
- 1646 Da
These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.
Source record
References
National Center for Biotechnology Information
PubChem Compound Summary: Afamelanotide
Authoritative identity record for the compound described as Melanotan-1.
PubChem · View source ↗National Center for Biotechnology Information
PubChem Compound Summary: Alpha-melanocyte-stimulating hormone
Authoritative identity record for the alpha-MSH parent-peptide context.
PubChem · View source ↗Stanislaus V, et al. · 2023
A feasibility and safety study of afamelanotide in acute stroke patients - an open label, proof of concept, phase iia clinical trial
Primary clinical research report for afamelanotide.
BMC Neurology · 10.1186/s12883-023-03338-9 View source ↗National Center for Biotechnology Information
PubChem compound record
PubChem · View source ↗Strathdee SA, Beyrer C · 2015
Threading the Needle--How to Stop the HIV Outbreak in Rural Indiana
The New England journal of medicine · View source ↗Minder EI, Barman-Aksoezen J, Schneider-Yin X · 2017
Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders
Clinical pharmacokinetics · View source ↗Wu J, Cotliar R · 2021



